Metropolis Healthcare (India) Today
| METROPOLIS | 1,850 13.45 0.73% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Metropolis Healthcare is selling at 1849.55 as of the 23rd of January 2025; that is 0.73 percent increase since the beginning of the trading day. The stock's open price was 1836.1. Metropolis Healthcare has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 24th of November 2024 and ending today, the 23rd of January 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Metropolis Healthcare is entity of India. It is traded as Stock on NSE exchange. The company has 51.28 M outstanding shares. More on Metropolis Healthcare Limited
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Metropolis Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Metropolis Healthcare's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Metropolis Healthcare or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Founder Chairman | Sushil Shah | ||||
| Thematic Idea | Health Management (View all Themes) | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Management, Health Care, Biotechnology, Diagnostics & Research, Healthcare (View all Sectors) | ||||
Metropolis Healthcare's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Metropolis Healthcare's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsMetropolis Healthcare can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Metropolis Healthcare's financial leverage. It provides some insight into what part of Metropolis Healthcare's total assets is financed by creditors.
| |||||
Metropolis Healthcare Limited (METROPOLIS) is traded on National Stock Exchange of India in India and employs 4,313 people. Metropolis Healthcare is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 95.83 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Metropolis Healthcare's market, we take the total number of its shares issued and multiply it by Metropolis Healthcare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Metropolis Healthcare operates under Biotechnology sector and is part of Health Care industry. The entity has 51.28 M outstanding shares.
Metropolis Healthcare Limited has accumulated about 198.82 M in cash with 2.64 B of positive cash flow from operations.
Check Metropolis Healthcare Probability Of Bankruptcy
Ownership AllocationMetropolis Healthcare maintains a total of 51.28 Million outstanding shares. Metropolis Healthcare Limited holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Metropolis Ownership Details
Metropolis Healthcare Risk Profiles
Although Metropolis Healthcare's alpha and beta are two of the key measurements used to evaluate Metropolis Healthcare's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.34 | |||
| Standard Deviation | 1.77 | |||
| Variance | 3.12 | |||
| Risk Adjusted Performance | (0.11) |
Metropolis Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Metropolis Healthcare without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
Metropolis Healthcare Corporate Management
Elected by the shareholders, the Metropolis Healthcare's board of directors comprises two types of representatives: Metropolis Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Metropolis. The board's role is to monitor Metropolis Healthcare's management team and ensure that shareholders' interests are well served. Metropolis Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Metropolis Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pinakin Shah | Chief Officer | Profile | |
| Neha Shah | Interim Secretary | Profile | |
| Simmi Bisht | Company Secretarial | Profile | |
| Ishita Medhekar | Chief Officer | Profile | |
| Kirti Chadha | Chief Officer | Profile | |
| Abdur Razzaque | Group Head | Profile |
Other Information on Investing in Metropolis Stock
Metropolis Healthcare financial ratios help investors to determine whether Metropolis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Metropolis with respect to the benefits of owning Metropolis Healthcare security.